In this interview, Dr Antonella Tosti discusses a study focused on alopecia as an emerging adverse event associated with calcitonin gene-related peptide monoclonal antibodies, which are commonly used for migraine treatment.
In this interview, Dr Antonella Tosti discusses a study focused on alopecia as an emerging adverse event associated with calcitonin gene-related peptide monoclonal antibodies, which are commonly used for migraine treatment.
In this interview, Dr Antonella...